| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 2 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 63.9K | $33.0K | - | |
| Dir | 28.4K | $14.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 30,865 | $0.41 | $12,500.33 | +17.0% | -23.8% | -76.2% | |
| Mar 21, 2024 | Bryan Nancy | Director | Buy | 38,462 | $0.39 | $15,000.18 | New | +2.6% | -63.2% | |
| Mar 15, 2024 | Appelrouth Stewart | Director | Buy | 90,910 | $0.33 | $30,000.30 | +61.1% | +24.2% | -63.6% | |
| Mar 15, 2024 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 37,879 | $0.33 | $12,500.07 | +26.3% | +24.2% | -63.6% | |
| Mar 15, 2024 | Equels Thomas K | CEO &President | Buy | 75,758 | $0.33 | $25,000.14 | +11.8% | +24.2% | -63.6% | |
| Nov 27, 2023 | Equels Thomas K | CEO &President | Buy | 33,861 | $0.44 | $15,000.42 | +5.6% | -4.7% | -46.5% | |
| Sep 29, 2023 | Equels Thomas K | CEO &President | Buy | 22,676 | $0.44 | $10,000.12 | +3.9% | +4.3% | -39.1% | |
| Aug 25, 2023 | Equels Thomas K | CEO &President | Buy | 8,222 | $0.67 | $5,500.52 | +1.4% | -35.8% | -44.8% | |
| Aug 24, 2023 | Equels Thomas K | CEO &President | Buy | 14,993 | $0.67 | $10,000.33 | +2.7% | -35.8% | -44.8% | |
| Jul 17, 2023 | Equels Thomas K | CEO &President | Buy | 16,950 | $0.59 | $10,000.50 | +3.1% | -25.8% | -35.5% |